Blocking the expression of STAT3, the phosphorylated form of which is detected in approximately 70% of cancers, results in the inhibition of tumour cell proliferation in in vitro assays and the inhibition of tumour progression in vivo [83]. This evidence concerns the gene STAT3 and neoplasm.